Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-22-015976

EVP, Chief Scientific Officer sold 1,148 shares at $112.25 ($128,863)

  • EVP, Chief Scientific Officer acquired 13,816 shares (grant or award)
  • EVP, Chief Scientific Officer acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sepp-Lorenzino Laura · EVP, Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-01 Exercise or conversion : show line 1 in the form +3,500 5,963 D
2022-01-01 Sale : show line 2 in the form −1,148 $112.25 $128,863 4,815 D
2022-03-01 Grant or award : show line 3 in the form +13,816 18,631 D
Open-market sales · 1,148 sh · avg $112.25 · $128,863

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-01-01 Exercise or conversion : show line 4 in the form Restricted Stock Unit −3,500 10,500 D
2022-03-01 Grant or award : show line 5 in the form Stock Option (right to buy) +13,816 13,816 D
Loading xslF345X03/doc4.xml…